Basecamp Research leverages knowledge of the natural world to create medicines, food and products using nature-inspired biodesign and AI-driven protein discovery.

Basecamp Research

Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraph™, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. 

Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and learn from nature's diversity, whilst delivering life-changing breakthroughs to those who need them most. 

Blue Horizon Corporation

Hummingbird Ventures

Systemiq capital

True Ventures

Valo Ventures

🔔 Today Basecamp Research announced #BaseFold, a breakthrough in predicting the 3D structures of large, complex proteins. We show that we can better predict the way proteins behave — not with better algorithms, but with higher-quality data.

🌎  By leveraging our purpose-built, foundational dataset of global #biodiversity, we improve the accuracy of AlphaFold2 structures by up to 6X, and the accuracy of small molecule docking by up to 3X.

🚀 BaseFold marks another significant step forward in #AI-based #drugdevelopment, offering more reliable predictions for therapeutic targets and drug interactions.

📖 Read our full announcement: https://lnkd.in/enPke4ri
And preprint here: https://lnkd.in/ersMs4NV

🖊️ Sifted wrote "How this UK startup improved DeepMind’s AlphaFold 6x": https://lnkd.in/e2NABB9N

🗞️ Forbes wrote "This startup says it can beat DeepMind’s game-changing protein AI": https://lnkd.in/e8w69pD7

#AI #Innovation #DrugDiscovery #AlphaFold  #Biotechnology

Bloomberg interviewed Basecamp Research Co-founder Glen Gowers ahead of next week's UN biodiversity talks in Montreal where nations and industry will discuss how to equitably share benefits of digital sequencing information from nature that will fuel future drug discovery in the age of AI.

Read the article here: https://bloom.bg/4fFgCYP

Feeling super energized after returning from a week in London during which I had a chance to review Basecamp Research’s momentum in building Biodiversity Collaborations around the world. Co-Founders Oliver Vince and Glen Gowers invited me to join the team in April 2021 to help lead and guide the company in the development of a Biodiversity Collaboration program building on my Biodiversity Access and Benefit Sharing experience starting in 1995 and building a similar program as the one that I led at Diversa from 2000 to 2006. To date Basecamp Research has sampled more than 50% of the world’s biomes through more than 100 expeditions in 23 countries.  These super impressive accomplishments have helped us discover and design novel proteins to tackle some of the world’s toughest problems.

All of this has been accomplished with our amazing team working on developing this industry leading Biodiversity Collaborations program with thanks to Bupe Mwambingu,  Emma Bolton, Glen Gowers, Ineke Knot, Marlon Clark, Nadine Greenhalgh, Neem Jitendrakumar Patel, PhD, Oliver Vince, and Phoebe Oldach.

Stay tuned for more announcements coming soon!

Later today I have the great privilege of representing Basecamp Research,  joining a panel on the topic of Foundation Models in Biology as well as hosting a roundtable discussion on genAI in Bio at the New York Stock Exchange organised by the incredible Decoding Bio team. Can't wait to reconnect and catch up with everyone in the field. #genAI #bio

Basecamp Research's CTO Philipp Lorenz spoke to The Stack about mapping the tree of life and navigating the data challenges along the way.

COM:BASECAMP-RESEARCH

Basecamp Research